Showing 1241-1250 of 4174 results for "".
Increasing Exposure for Genital Psoriasis
https://practicaldermatology.com/videos/skin-minute/increasing-exposure-for-genital-psoriasis/67119/Michael J. Payette, MD, MBA, discusses a paper he authored in the American Journal of Clinical Dermatology that provides clinically practical, age-specific guidance for diagnosing and managing genital psoriasis across pediatric, adult, and older populations.Graduating from Dermatology Residency into the COVID-19 Job Market
https://practicaldermatology.com/youngmd-connect/resident-resource-center/graduating-from-dermatology-residency-into-the-covid-19-job-market/23437/Third-year dermatology residents are graduating into an uncertain job market. What does the future hold?Practical Dermatology Roundtable: Reclaiming Urticaria, Ch. 4
https://practicaldermatology.com/programs/practical-dermatology/practical-dermatology-roundtable-reclaiming-urticaria-ch-4/84989/In the fourth installment of this five-part series, Brad P. Glick, DO, MPH, FAAD; Laura K. Ferris, MD, PhD; and Lawrence J. Green, MD, FAAD, discuss the quality-of-life burden of CSU, practical antihistamine escalation, and how to choose among injectable and oral targeted therapies.Practical Dermatology Roundtable: Reclaiming Urticaria, Ch. 3
https://practicaldermatology.com/programs/practical-dermatology/practical-dermatology-roundtable-reclaiming-urticaria-ch-3/84988/In the third installment of this five-part series, Brad P. Glick, DO, MPH, FAAD; Laura K. Ferris, MD, PhD; and Lawrence J. Green, MD, FAAD, examine the immunologic pathways underlying CSU, including mast-cell activation, IgE and IgG mechanisms, BTK inhibition, and distinctions from chronic induciblePractical Dermatology Roundtable: Reclaiming Urticaria, Ch. 2
https://practicaldermatology.com/programs/practical-dermatology/practical-dermatology-roundtable-reclaiming-urticaria-ch-2/84987/In the second installment of this five-part series, Brad P. Glick, DO, MPH, FAAD; Laura K. Ferris, MD, PhD; and Lawrence J. Green, MD, FAAD review key diagnostic clues that distinguish CSU from urticarial vasculitis and inducible urticaria, while addressing angioedema and practical treatment optionsThoughts on Superpotent Topical Corticosteroids in Children
https://practicaldermatology.com/topics/psoriasis/thoughts-on-superpotent-topical-corticosteroids-in-children/18684/"I think we've been overtrained that atrophy occurs all the time," says Neil J. Korman, MD. Caution is essential, but super potent topical corticosteroids can be used safely and effectively for pediatric psoriasis patients, he says. Jerry Bagel, MD agrees, in this bonus video from the Clinical ConveStevens-Johnson Syndrome: A Case Report
https://practicaldermatology.com/youngmd-connect/resident-resource-center/stevens-johnson-syndrome-a-case-series/23902/Successful treatment of drug-induced Stevens-Johnson Syndrome using cyclosporine and etanercept.Selecting the Optimal JAK Inhibitor for Alopecia Areata
https://practicaldermatology.com/topics/hair-nails/selecting-the-optimal-jak-inhibitor-for-alopecia-areata/67265/Since 2022, the US Food and Drug Administration (FDA) has approved three oral JAK inhibitors: baricitinib, ritlecitinib, and deuruxolitinib.The Benefits of Private Practice: A Q&A with Joel Schlessinger, MD, FAAD
https://practicaldermatology.com/issues/september-2025/the-benefits-of-private-practice-a-qa-with-joel-schlessinger-md-faad/37630/While selling to and working for private equity–backed platforms may have its perks, many long-time private practitioners warn that the advantages of private practice are often not fully appreciated until it is too late. Practical Dermatology Chief Cosmetic Surgery Editor Emeritus Joel Schlessinger,Practical Dermatology Roundtable: Reclaiming Urticaria, Ch. 1
https://practicaldermatology.com/programs/practical-dermatology/practical-dermatology-roundtable-reclaiming-urticaria-ch-1/84986/In the first installment of this five-part series, Brad P. Glick, DO, MPH, FAAD; Laura K. Ferris, MD, PhD; and Lawrence J. Green, MD, FAAD, discuss why chronic spontaneous urticaria care drifted toward allergy practices and how dermatologists can bring patients back with streamlined evaluation and e